Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Almorexant> ?p ?o. }
Showing items 1 to 69 of
69
with 100 items per page.
- Almorexant abstract "Almorexant (INN, codenamed ACT-078573) is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011.".
- Almorexant atcPrefix "none".
- Almorexant casNumber "871224-64-5".
- Almorexant fdaUniiCode "9KCW39P2EI".
- Almorexant iupacName "(2R)-2-[(1S)- 6,7-dimethoxy- 1-{2-[4-(trifluoromethyl)phenyl]ethyl}- 3,4-dihydroisoquinolin-2(1H)-yl]- N-methyl- 2-phenylacetamide".
- Almorexant pubchem "23727689".
- Almorexant thumbnail Almorexant.svg?width=300.
- Almorexant wikiPageExternalLink www.actelion.com.
- Almorexant wikiPageID "19451365".
- Almorexant wikiPageRevisionID "546277646".
- Almorexant atcPrefix "none".
- Almorexant c "29".
- Almorexant casNumber "871224".
- Almorexant chembl "455136".
- Almorexant chemspiderid "21377865".
- Almorexant cl "1".
- Almorexant f "3".
- Almorexant h "32".
- Almorexant hasPhotoCollection Almorexant.
- Almorexant inchi "1".
- Almorexant inchikey "DKMACHNQISHMDN-RPLLCQBOBT".
- Almorexant iupacName "-2".
- Almorexant metabolism Liver.
- Almorexant molecularWeight "512.6".
- Almorexant n "2".
- Almorexant o "3".
- Almorexant pubchem "23727689".
- Almorexant routesOfAdministration "Oral".
- Almorexant smiles "CNC[C@@H]N2CCC3=CCOC".
- Almorexant stdinchi "1".
- Almorexant stdinchikey "DKMACHNQISHMDN-RPLLCQBOSA-N".
- Almorexant unii "9".
- Almorexant verifiedfields "changed".
- Almorexant verifiedrevid "477318417".
- Almorexant subject Category:Acetamides.
- Almorexant subject Category:Orexin_antagonists.
- Almorexant subject Category:Organofluorides.
- Almorexant subject Category:Phenol_ethers.
- Almorexant subject Category:Sedatives.
- Almorexant subject Category:Tetrahydroisoquinolines.
- Almorexant type Abstraction100002137.
- Almorexant type Acetamide114711197.
- Almorexant type Acetamides.
- Almorexant type Amide114724264.
- Almorexant type Chemical114806838.
- Almorexant type Compound114818238.
- Almorexant type Element114840755.
- Almorexant type Material114580897.
- Almorexant type Matter100020827.
- Almorexant type OrganicCompound114727670.
- Almorexant type Part113809207.
- Almorexant type PhenolEthers.
- Almorexant type PhysicalEntity100001930.
- Almorexant type Quintessence114847103.
- Almorexant type Relation100031921.
- Almorexant type Substance100019613.
- Almorexant type Drug.
- Almorexant type DrugProduct.
- Almorexant type FunctionalSubstance.
- Almorexant comment "Almorexant (INN, codenamed ACT-078573) is an orexin antagonist, functioning as a competitive receptor antagonist of the OX1 and OX2 orexin receptors, which was being developed by the pharmaceutical companies Actelion and GSK for the treatment of insomnia. Development of the drug was abandoned in January 2011.".
- Almorexant label "Almorexant".
- Almorexant sameAs m.04n50zm.
- Almorexant sameAs Q4355941.
- Almorexant sameAs Q4355941.
- Almorexant sameAs Almorexant.
- Almorexant wasDerivedFrom Almorexant?oldid=546277646.
- Almorexant depiction Almorexant.svg.
- Almorexant homepage www.actelion.com.
- Almorexant isPrimaryTopicOf Almorexant.
